Qiang Zhang1, Shuai Yang2, Xian-ying Meng3, Guang Chen2, Ren-zhu Pang2. 1. Department of Thyroid Surgery, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, People's Republic of China. jluzhangqiang@163.com. 2. Department of Thyroid Surgery, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, People's Republic of China. 3. Department of Thyroid Surgery, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, People's Republic of China. 7919728@qq.com.
Abstract
OBJECTIVE: To analyze the clinical characteristics of familial nonmedullary thyroid carcinoma (FNMTC), in order to provide evidence for early diagnosis and treatment. METHODS: We retrospectively investigated the inpatients between September 2006 and September 2013 in the First Bethune Hospital of Jilin University, in which 78 patients with FNMTC from 31 families were analyzed by a comparison with 3445 control cases from the patients with sporadic nonmedullary thyroid carcinoma (SNMTC). RESULTS: There was no significant difference in gender, age, and tumor size between FNMTC and SNMTC patients. However, the characteristics of disease in multifoci, neck lymph node metastasis, invasion to the surrounding tissues, and coexistence with Hashimoto disease in two types of cancer patients show significant difference. They are: multifoci: 71.8% (56/78) in FNMTC versus 46.3% (1595/3445) in SNMTC; neck lymph node metastasis: 52.6% (41/78) in FNMTC versus 33.3% (1148/3445) in SNMTC; surrounding tissue invasion: 64.1% (50/78) in FNMTC versus 48.5% (1670/3445) in SNMTC; coexistence with Hashimoto disease: 30.8% (24/78) in FNMTC versus 20.0% (689/3445) in SNMTC. CONCLUSION: Lymph node metastasis, multifoci, invasion to the surrounding tissues, and combination with chronic lymphocytic thyroiditis are the main features of FNMTC, which suggests the extent of the operation for FNMTC patients should be amplified properly.
OBJECTIVE: To analyze the clinical characteristics of familial nonmedullary thyroid carcinoma (FNMTC), in order to provide evidence for early diagnosis and treatment. METHODS: We retrospectively investigated the inpatients between September 2006 and September 2013 in the First Bethune Hospital of Jilin University, in which 78 patients with FNMTC from 31 families were analyzed by a comparison with 3445 control cases from the patients with sporadic nonmedullary thyroid carcinoma (SNMTC). RESULTS: There was no significant difference in gender, age, and tumor size between FNMTC and SNMTC patients. However, the characteristics of disease in multifoci, neck lymph node metastasis, invasion to the surrounding tissues, and coexistence with Hashimoto disease in two types of cancerpatients show significant difference. They are: multifoci: 71.8% (56/78) in FNMTC versus 46.3% (1595/3445) in SNMTC; neck lymph node metastasis: 52.6% (41/78) in FNMTC versus 33.3% (1148/3445) in SNMTC; surrounding tissue invasion: 64.1% (50/78) in FNMTC versus 48.5% (1670/3445) in SNMTC; coexistence with Hashimoto disease: 30.8% (24/78) in FNMTC versus 20.0% (689/3445) in SNMTC. CONCLUSION: Lymph node metastasis, multifoci, invasion to the surrounding tissues, and combination with chronic lymphocytic thyroiditis are the main features of FNMTC, which suggests the extent of the operation for FNMTC patients should be amplified properly.
Authors: Young Joo Park; Hwa Young Ahn; Hoon Sung Choi; Kyung Won Kim; Do Joon Park; Bo Youn Cho Journal: Thyroid Date: 2012-01-26 Impact factor: 6.568
Authors: Haggi Mazeh; Joy Benavidez; Jennifer L Poehls; Linda Youngwirth; Herbert Chen; Rebecca S Sippel Journal: Thyroid Date: 2011-12-02 Impact factor: 6.568
Authors: M Capezzone; S Marchisotta; S Cantara; G Busonero; L Brilli; K Pazaitou-Panayiotou; A F Carli; G Caruso; P Toti; S Capitani; A Pammolli; F Pacini Journal: Endocr Relat Cancer Date: 2008-10-02 Impact factor: 5.678
Authors: Thomas J McDonald; Albert A Driedger; Bertha M Garcia; Stanislaus H M Van Uum; Irina Rachinsky; Vijaya Chevendra; Daniel Breadner; Richard Feinn; Stephen J Walsh; Carl D Malchoff Journal: J Oncol Date: 2011-10-25 Impact factor: 4.375
Authors: I J Nixon; C Suárez; R Simo; A Sanabria; P Angelos; A Rinaldo; J P Rodrigo; L P Kowalski; D M Hartl; M L Hinni; J P Shah; A Ferlito Journal: Eur J Surg Oncol Date: 2016-08-11 Impact factor: 4.424
Authors: María Sánchez-Ares; Soledad Cameselle-García; Ihab Abdulkader-Nallib; Gemma Rodríguez-Carnero; Carolina Beiras-Sarasquete; José Antonio Puñal-Rodríguez; José Manuel Cameselle-Teijeiro Journal: Front Endocrinol (Lausanne) Date: 2022-02-28 Impact factor: 5.555